§ 02Everything you need to get started
four surfaces · one directory01glphelper.com/ozempic/[state]
Find a provider
Doctors, clinics, and pharmacies near you.
Searchable by state and city. Filter by insurance, telehealth, and current waitlist. NPI-verified.
1,800+ providers · 50 states→
FILTERS
→ State: Texas
→ Insurance: BCBS
→ Telehealth: yes
→ Wait: ≤14d
47 results
02glphelper.com/compare
Compare medications
GLP-1s side by side.
Ozempic, Wegovy and the rest of the class — facts cited to FDA labels and clinical trials. Brand vs generic, dose vs dose.
6 medications · 17 endpoints→
03glphelper.com/chat
Ask the chatbot
AI-powered, citation-anchored.
Trained exclusively on FDA labels, peer-reviewed literature, and CMS coverage policy. Inline citations on every claim.
Free · no signup · cites every claim→
USER
Will BCBS cover Wegovy off-label?
glp·helper
Most commercial plans deny Wegovy for weight loss without PA[5]...
04glphelper.com/blog
Read the research
Evidence-backed guides.
Medication deep-dives, mechanism explainers, and breakdowns of new trial data. Plain language, full citations.
Growing weekly→
RESEARCH · 2026
What the new semaglutide MASH data actually means.
12 MIN READ · 8 CITATIONS
§ 03Why we cite everything
editorial standardsEvery medical claim is cited to its source.
Hover any chip — like the one beside this claim[2]— and you'll see the original FDA label, peer-reviewed paper, or CMS policy document. We don't paraphrase marketing materials and we don't link out to other SEO content. Just the primary sources.
EXAMPLE · CITATION CHIP
“Semaglutide reduced major adverse cardiac events by 26% in high-CV-risk T2D patients in the SUSTAIN-6 trial[2].”
[2]
NEJM. Marso SP et al. Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 2016;375:1834–44 (SUSTAIN-6).
6
GLP-1 medications covered
8
primary sources in our citation taxonomy
3,717
providers indexed across the US
50
states · 45 cities